BridgeBio Pharma Inc
BBIO
Market Cap$6.5B
Close$
$-9.00
123.5% downside
Current Fair Value
123.5% downsideOvervalued by 123.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.50 Billion |
|---|---|
| Enterprise Value | $5.98 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.88 |
| Beta | 1.15 |
| Outstanding Shares | 190,145,253 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.75 |
|---|---|
| PEG | -2.6 |
| Price to Sales | - |
| Price to Book Ratio | -4.26 |
| Enterprise Value to Revenue | 46.97 |
| Enterprise Value to EBIT | -8.87 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | -0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About BridgeBio Pharma Inc
CEO: Neil Kumar